Andrew Dahl, BioMEMS Diagnostics - Portable, In-Vitro Diagnostics Platform | LSI Europe '22

BioMEMS has developed a handheld, portable, in-vitro diagnostics platform that can analyze samples in under 3 minutes. The company's point-of-care platform is capable of analyzing samples from blood, mucus, urine and saliva.
Speakers
Andrew Dahl
Andrew Dahl
Founder & Chairman, BioMEMS Diagnostics